Literature DB >> 25648687

Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice.

Ł Krych1, D S Nielsen, A K Hansen, C H F Hansen.   

Abstract

Gut microbiota regulated imbalances in the host's immune profile seem to be an important factor in the etiology of type 1 diabetes (T1D), and identifying bacterial markers for T1D may therefore be useful in diagnosis and prevention of T1D. The aim of the present study was to investigate the link between the early gut microbiota and immune parameters of non-obese diabetic (NOD) mice in order to select alleged bacterial markers of T1D. Gut microbial composition in feces was analyzed with 454/FLX Titanium (Roche) pyro-sequencing and correlated with diabetes onset age and immune cell populations measured in diabetic and non-diabetic mice at 30 weeks of age. The early gut microbiota composition was found to be different between NOD mice that later in life were classified as diabetic or non-diabetic. Those differences were further associated with changes in FoxP3(+) regulatory T cells, CD11b(+) dendritic cells, and IFN-γ production. The model proposed in this work suggests that operational taxonomic units classified to S24-7, Prevotella, and an unknown Bacteriodales (all Bacteroidetes) act in favor of diabetes protection whereas members of Lachnospiraceae, Ruminococcus, and Oscillospira (all Firmicutes) promote pathogenesis.

Entities:  

Keywords:  CD, cluster of differentiation; DC, dendritic cell; FoxP3, forkhead box; IFN, interferon; IFN-γ; MLN, mesenteric lymph node; NKT, natural killer T cell; NOD mice; PCA, principal component analysis; PCoA, principal coordinate analysis; PLN, pancreatic lymph node; Treg, regulatory T cell; Type 1 diabetes; gut microbiota; regulatory immunity; siLP, small intestinal lamina propria

Mesh:

Substances:

Year:  2015        PMID: 25648687      PMCID: PMC4615729          DOI: 10.1080/19490976.2015.1011876

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  37 in total

1.  Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation.

Authors:  Fabienne Billiard; Elena Litvinova; David Saadoun; Fathia Djelti; David Klatzmann; José L Cohen; Gilles Marodon; Benoît L Salomon
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

2.  Development and cytolytic function of intestinal intraepithelial T lymphocytes in antigen-minimized mice.

Authors:  M Kawaguchi-Miyashita; K Shimizu; M Nanno; S Shimada; T Watanabe; Y Koga; Y Matsuoka; H Ishikawa; K Hashimoto; M Ohwaki
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

3.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

4.  Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells.

Authors:  Martin A Kriegel; Chozhavendan Rathinam; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-10       Impact factor: 11.205

5.  Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response.

Authors:  Megan Livingston; Diane Loach; Michelle Wilson; Gerald W Tannock; Margaret Baird
Journal:  Immunol Cell Biol       Date:  2009-09-29       Impact factor: 5.126

6.  Quantitatively different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view towards the human gut microbiome.

Authors:  Lukasz Krych; Camilla H F Hansen; Axel K Hansen; Frans W J van den Berg; Dennis S Nielsen
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

7.  Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.

Authors:  Christopher T Brown; Austin G Davis-Richardson; Adriana Giongo; Kelsey A Gano; David B Crabb; Nabanita Mukherjee; George Casella; Jennifer C Drew; Jorma Ilonen; Mikael Knip; Heikki Hyöty; Riitta Veijola; Tuula Simell; Olli Simell; Josef Neu; Clive H Wasserfall; Desmond Schatz; Mark A Atkinson; Eric W Triplett
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

8.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

9.  Foxp3(+) regulatory T cells in mouse models of type 1 diabetes.

Authors:  Cathleen Petzold; Julia Riewaldt; Deepika Watts; Tim Sparwasser; Sonja Schallenberg; Karsten Kretschmer
Journal:  J Diabetes Res       Date:  2013-03-14       Impact factor: 4.011

10.  Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice.

Authors:  Amandine Everard; Sébastien Matamoros; Lucie Geurts; Nathalie M Delzenne; Patrice D Cani
Journal:  mBio       Date:  2014-06-10       Impact factor: 7.867

View more
  50 in total

1.  Heminiphilus faecis gen. nov., sp. nov., a member of the family Muribaculaceae, isolated from mouse faeces and emended description of the genus Muribaculum.

Authors:  Jun Kyu Park; Dong-Ho Chang; Moon-Soo Rhee; Haeyoung Jeong; Jinhoi Song; Bon Jeong Ku; Seung Bum Kim; Mina Lee; Byoung-Chan Kim
Journal:  Antonie Van Leeuwenhoek       Date:  2021-02-10       Impact factor: 2.271

2.  Distinct roles for dietary lipids and Porphyromonas gingivalis infection on atherosclerosis progression and the gut microbiota.

Authors:  Carolyn D Kramer; Alexandra M Simas; Xianbao He; Robin R Ingalls; Ellen O Weinberg; Caroline Attardo Genco
Journal:  Anaerobe       Date:  2017-04-23       Impact factor: 3.331

3.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

Review 4.  Select Polyphenol-Rich Berry Consumption to Defer or Deter Diabetes and Diabetes-Related Complications.

Authors:  Ahsan Hameed; Mauro Galli; Edyta Adamska-Patruno; Adam Krętowski; Michal Ciborowski
Journal:  Nutrients       Date:  2020-08-21       Impact factor: 5.717

5.  Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogeny.

Authors:  Michael Silverman; Lindsay Kua; Alessandro Tanca; Mauro Pala; Antonio Palomba; Ceylan Tanes; Kyle Bittinger; Sergio Uzzau; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-22       Impact factor: 11.205

6.  Bisphenol A alteration of type 1 diabetes in non-obese diabetic (NOD) female mice is dependent on window of exposure.

Authors:  Joella Xu; Guannan Huang; Tamas Nagy; Tai L Guo
Journal:  Arch Toxicol       Date:  2019-03-02       Impact factor: 5.153

7.  Sex-dependent effects of bisphenol A on type 1 diabetes development in non-obese diabetic (NOD) mice.

Authors:  Joella Xu; Guannan Huang; Tamas Nagy; Quincy Teng; Tai L Guo
Journal:  Arch Toxicol       Date:  2019-01-02       Impact factor: 5.153

8.  Comparison of Diet versus Exercise on Metabolic Function and Gut Microbiota in Obese Rats.

Authors:  Rebecca J Welly; Tzu-Wen Liu; Terese M Zidon; Joe L Rowles; Young-Min Park; T Nicholas Smith; Kelly S Swanson; Jaume Padilla; Victoria J Vieira-Potter
Journal:  Med Sci Sports Exerc       Date:  2016-09       Impact factor: 5.411

9.  Changes in the gut microbiota: a possible factor influencing peripheral blood immune indexes in non-obese diabetic mice.

Authors:  Yiling Wu; Qi You; Jingjin Fei; Jie Wu
Journal:  Antonie Van Leeuwenhoek       Date:  2021-08-09       Impact factor: 2.271

10.  Host Genetic Background and Gut Microbiota Contribute to Differential Metabolic Responses to Fructose Consumption in Mice.

Authors:  In Sook Ahn; Jennifer M Lang; Christine A Olson; Graciel Diamante; Guanglin Zhang; Zhe Ying; Hyae Ran Byun; Ingrid Cely; Jessica Ding; Peter Cohn; Ira Kurtz; Fernando Gomez-Pinilla; Aldons J Lusis; Elaine Y Hsiao; Xia Yang
Journal:  J Nutr       Date:  2020-10-12       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.